These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25714444)

  • 1. The usefulness of a cholesterol absorption inhibitor in Japanese type 2 diabetes patients with dyslipidemia.
    Katsura T; Katakami N; Irie Y; Yamamoto Y; Okusu T; Kubo F; Kanamaru Y; Nakashoutani I; Yoshiuchi K; Sakamoto K; Kaneto H; Shimomura I; Kosugi K
    Diabetes Technol Ther; 2015 Jun; 17(6):427-34. PubMed ID: 25714444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia.
    Hiramitsu S; Ishiguro Y; Matsuyama H; Yamada K; Kato K; Noba M; Uemura A; Yoshida S; Matsubara Y; Kani A; Hasegawa K; Hishida H; Ozaki Y
    J Atheroscler Thromb; 2010 Feb; 17(1):106-14. PubMed ID: 20075600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of plant sterols, lathosterol, oxidative stress and inflammatory markers after the combination therapy of ezetimibe and statin drugs in type 2 diabetic patients.
    Naruse R; Hori K; Terasawa T; Hara K; Suetsugu M; Takebayashi K; Morita K; Aso Y; Inukai T
    Obes Res Clin Pract; 2015; 9(1):67-74. PubMed ID: 25660177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of rosuvastatin/ezetimibe association for the treatment of hypercholesterolemia and mixed dyslipidemia.
    Strilchuk L; Tocci G; Fogacci F; Cicero AFG
    Expert Opin Pharmacother; 2020 Apr; 21(5):531-539. PubMed ID: 32036729
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene polymorphism and frequencies of the NPC1L1 gene (rs2072183, rs217434 and rs217428) in Japanese patients with dyslipidemia.
    Kashiwabara Y; Kobayashi Y; Koba S; Kohyama N; Ohbayashi M; Murayama JI; Hirano T; Kobayashi Y; Yamamoto T
    J Clin Pharm Ther; 2014 Oct; 39(5):551-4. PubMed ID: 24861377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance.
    Rivers SM; Kane MP; Busch RS; Bakst G; Hamilton RA
    Endocr Pract; 2007; 13(1):11-6. PubMed ID: 17360295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ezetimibe on cholesterol absorption and lipoprotein composition in diabetes and metabolic syndrome.
    Federici M
    Atheroscler Suppl; 2015 Feb; 17():17-22. PubMed ID: 25659872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering effects of ezetimibe for hypercholesterolemic patients with and without type 2 diabetes mellitus.
    Okada K; Yagyu H; Kotani K; Miyamoto M; Osuga J; Nagasaka S; Ishibashi S
    Endocr J; 2010; 57(10):903-8. PubMed ID: 20733267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of ezetimibe added to statin therapy in patients with primary dyslipidaemia not achieving the LDL-C treatment goal on statin monotherapy.
    González CA; Rubio-Guerra AF; Pavía A; Redding FJ; Cervantes JL; Zacarías JL; Yza R; Carranza J; Fernández P; Morales E; Robles FJ; Leyva JL; Rodríguez L
    Clin Drug Investig; 2007; 27(5):333-7. PubMed ID: 17451281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-dose pravastatin versus add-on ezetimibe with low-dose pravastatin - effects on LDL cholesterol, cholesterol absorption, and cholesterol synthesis in Japanese patients with hypercholesterolemia (PEAS study).
    Sasaki J; Otonari T; Sawayama Y; Hata S; Oshima Y; Saikawa T; Biro S; Kono S;
    J Atheroscler Thromb; 2012; 19(5):485-93. PubMed ID: 22659533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ezetimibe on cholesterol metabolism in HIV-infected patients with protease inhibitor-associated dyslipidemia: a single-arm intervention trial.
    Leyes P; Martínez E; Larrousse M; Cofán M; Trabal J; Pérez-Heras AM; Forga MT; Ros E
    BMC Infect Dis; 2014 Sep; 14():497. PubMed ID: 25209653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ezetimibe in patients undergoing hemodialysis.
    Hattori S; Hattori Y
    Endocr J; 2010; 57(11):1001-5. PubMed ID: 20885068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Ezetimibe Monotherapy on Low-Density Lipoprotein Cholesterol and on Markers of Cholesterol Synthesis and Absorption in Japanese Patients With Hypercholesterolemia.
    Ohta A; Kato H; Ishii S; Nagai Y; Tanaka Y
    J Clin Med Res; 2017 Jun; 9(6):476-481. PubMed ID: 28496547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usefulness of additional treatment with ezetimibe in patients with coronary artery disease on statin therapy. - From the viewpoint of cholesterol metabolism.-.
    Okada K; Kimura K; Iwahashi N; Endo T; Himeno H; Fukui K; Kobayashi S; Shimizu M; Iwasawa Y; Morita Y; Wada A; Shigemasa T; Mochida Y; Shimizu T; Sawada R; Uchino K; Umemura S
    Circ J; 2011; 75(10):2496-504. PubMed ID: 21817821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of simvastatin and ezetimibe in lowering low-density lipoprotein cholesterol in subjects with type 1 and type 2 diabetes mellitus.
    Ciriacks K; Coly G; Krishnaswami S; Patel SB; Kidambi S
    Metab Syndr Relat Disord; 2015 Mar; 13(2):84-90. PubMed ID: 25490061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ezetimibe as monotherapy or combination therapy in hypercholesterolemic patients with and without diabetes.
    Kishimoto M; Sugiyama T; Osame K; Takarabe D; Okamoto M; Noda M
    J Med Invest; 2011 Feb; 58(1-2):86-94. PubMed ID: 21372492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial.
    Jakulj L; Vissers MN; Groen AK; Hutten BA; Lutjohann D; Veltri EP; Kastelein JJ
    J Lipid Res; 2010 Apr; 51(4):755-62. PubMed ID: 19828909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ezetimibe for Japanese patients with dyslipidaemia: The ESSENTIAL Study.
    Sawayama Y; Maeda S; Ohnishi H; Hayashi S; Hayashi J
    Clin Drug Investig; 2010; 30(3):157-66. PubMed ID: 20155988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin 10 mg plus ezetimibe 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease.
    Uemura Y; Watarai M; Ishii H; Koyasu M; Takemoto K; Yoshikawa D; Shibata R; Matsubara T; Murohara T
    J Cardiol; 2012 Jan; 59(1):50-6. PubMed ID: 22100058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.